Molecular basis of inherited colorectal carcinomas in the Macedonian population: An update

• Published in: Balkan journal of medical genetics Vol. 22; no. 2; pp. 5 - 16
• Main Authors: Staninova-Stojovska, M, Matevska-Geskovska, N, Panovski, M, Angelovska, B, Mitrevski, N, Ristevski, M, Jovanovic, R, Dimovski, AJ
• Format: Journal Article
• Language: English
• Published: Poland Sciendo 21.12.2019; De Gruyter Poland
• Subjects: Adenomatous polyposis coli; Colorectal cancer; Colorectal carcinoma; Deoxyribonucleic acid; DNA; DNA repair; Familial adenomatous polyposis; Genetic screening; Hereditary colorectal cancer (CRC); Macedonian population; Microsatellite instability; Mismatch repair; Mutation; mutations; Next-generation sequencing; Original; Tumors; Hereditary colorectal cancer (CRC); mutations; Macedonian population
• ISSN: 1311-0160; 2199-5761; 1311-0160
• DOI: 10.2478/bjmg-2019-0027

Hereditary factors are assumed to play a role in ~35.0-45.0% of all colorectal cancers (CRCs) with about 5.0-10.0% associated with high penetrant disease-causing mutations in genes correlated to hereditary polyposis (HP) or hereditary non polyposis syndromes (HNPCC). Although inherited germline mutations in mismatch repair (MMR) and the genes contribute significantly to CRC, genetic diagnosis cannot yet be obtained in more than 50.0% of familial cases. We present updated data of 107 probands from the Macedonian population with clinically diagnosed HP 41) or HNPCC ( 66) obtained by next generation sequencing (NGS) with three different gene panels covering the coding, flanking and promoter regions of 114 cancer predisposition genes. Using this approach, we were able to detect deleterious mutations in 65/107 (60.7%) patients, 50.4% of which were in known well-established CRC susceptibility genes and 10.2% in DNA repair genes (DRG). As expected, the highest frequencies of deleterious variants were detected in familial adenomatous polyposis (FAP) and in HNPCC patients with microsatellite instability (MSI) tumors (93.8 and 87.1%, respectively). Variants of unknown significance (VUS) were detected in 24/107 (22.4%) patients, mainly in HNPCC patients with microsatellite stable (MSS) tumors or patients with oligopolyposis. The majority of VUS were also found in DRG genes, indicating the potential role of a doble-strand brake DNA repair pathway deficiency in colorectal cancerogenesis. We could not detect any variant in 18/107 (16.8%) patients, which supports the genetic heterogeneity of hereditary CRC, particularly in HNPCC families with MSS tumors and in families with oligopolyposis.